IXHL (Incannex Healthcare) ROE % Adjusted to Book Value : -45.76% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Incannex Healthcare ROE % Adjusted to Book Value?

Incannex Healthcare's ROE % for the quarter that ended in Sep. 2024 was -243.43%. Incannex Healthcare's PB Ratio for the quarter that ended in Sep. 2024 was 5.32. Incannex Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -45.76%.

Incannex Healthcare ROE % Adjusted to Book Value Historical Data

The historical data trend for Incannex Healthcare's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare ROE % Adjusted to Book Value Chart

Incannex Healthcare Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.16

-38.38

-24.94

Incannex Healthcare Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-28.48	-36.27	-44.13	-45.76

Competitive Comparison of Incannex Healthcare's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incannex Healthcare's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Incannex Healthcare's ROE % Adjusted to Book Value falls into.

Incannex Healthcare ROE % Adjusted to Book Value Calculation

Incannex Healthcare's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-115.22%	/	4.62
	=	-24.94%

Incannex Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-243.43%	/	5.32
	=	-45.76%

Incannex Healthcare ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Incannex Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Inc (NAS:IXHL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000

Website

https://www.incannex.com.au

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.